Company record
Pico IV Inc.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Pico IV Inc..
Warning letters
-
DrugsPico IV Inc.
FDA warned Pico IV Inc. that its intravenous CBD product Pico IV is an unapproved new drug sold with drug claims.
High risk